...
首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis
【24h】

Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis

机译:将组蛋白脱乙酰酶活性阻断为过敏性鼻炎患者上皮阻挡缺陷的新靶标

获取原文
获取原文并翻译 | 示例
           

摘要

Background: A defective epithelial barrier is found in patients with allergic rhinitis (AR) and asthma; however, the underlying mechanisms remain poorly understood. Histone deacetylase (HDAC) activity has been identified as a crucial driver of allergic inflammation and tight junction dysfunction.
机译:背景:对过敏性鼻炎(AR)和哮喘的患者发现有缺陷的上皮屏障; 然而,潜在机制仍然明白很差。 组蛋白脱乙酰化酶(HDAC)活性已被鉴定为过敏性炎症和紧密结功能障碍的关键载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号